-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QdZk1s38oNtP4wXZBHkbrNX3o6p9Al9KS6++9BD7undwCeEfe78aF4zoUjl/nGC2 hLJP58OAP/EgoHBfzBJwJw== 0001179110-03-002917.txt : 20030702 0001179110-03-002917.hdr.sgml : 20030702 20030702144403 ACCESSION NUMBER: 0001179110-03-002917 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030701 FILED AS OF DATE: 20030702 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRUKER DALTONICS INC CENTRAL INDEX KEY: 0001109354 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043110160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 44 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 MAIL ADDRESS: STREET 1: 44 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FRANCIS LAURA CENTRAL INDEX KEY: 0001218802 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30833 FILM NUMBER: 03771278 BUSINESS ADDRESS: STREET 1: 5465 E CHERYL PKWY CITY: MADISON STATE: WI ZIP: 53719 BUSINESS PHONE: 6082763045 MAIL ADDRESS: STREET 1: 5465 E CHERYL PKWY CITY: MADISON STATE: WI ZIP: 53719 4 1 edgar.xml FORM 4 -2003-07-01 X0101 4 2003-07-01 0 0001109354 BRUKER DALTONICS INC BRKR 0001218802 FRANCIS LAURA 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 6.68 2003-07-01 4 A 0 50400 6.68 A 2003-03-27 2012-03-27 Common Stock 50400 50400 D Stock Option (right to buy) 3.06 2003-07-01 4 A 0 12600 3.06 A 2004-01-01 2013-01-01 Common Stock 12600 12600 D In connection with the merger of Bruker AXS Inc. into Bruker Daltonics Inc., now known as Bruker BioSciences Corporation (the "Merger"), filer's option to receive 80,000 shares of Bruker AXS Inc. common stock was converted into an option to purchase 50,400 shares of Bruker BioSciences Corporation common stock with the same vesting schedule at $6.68 per share. In connection with the Merger, filer's option to receive 20,000 shares of Bruker AXS Inc. common stock was converted into an option to purchase 12,600 shares of Bruker BioSciences Corporation common stock with the same vesting schedule at $3.06 per share. Laura Francis 2003-07-01 -----END PRIVACY-ENHANCED MESSAGE-----